Academic startups the most likely biotech beneficiaries from U.K. Future Fund

While VCs have broadly applauded the U.K. government for launching the £250 million Future Fund to provide financial aid to private companies hit by the pandemic, the size and structure of the fund makes it unlikely to be of much help for most U.K. biotechs. Preclinical academic startups are the exception.

Announced in April and launched last month, the Future Fund aims to match up to £5 million in private investment for innovative U.K. companies across all sectors of the economy. ...